StockData

Drugs Made In America Acquisition Corp. (DMAA) stock

DMAANasdaqBlank ChecksFiscal year ends December 31Also trades as DMAAR, DMAAU
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.90+0.00 (0.00%)

Close on Nov 17, 2026Market cap $264.62MP/E –Yield –

Drugs Made In America Acquisition pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Drugs Made In America Acquisition's pe ratio was 19.2× on Nov 11, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202619.2×–

More Drugs Made In America Acquisition figures

See a number that looks wrong?